Open10.600 | Close14.870 |
Vol / Avg.712.593K / 3.997K | Mkt Cap30.964M |
Day Range10.320 - 16.200 | 52 Wk Range8.465 - 42.000 |
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
Open10.600 | Close14.870 |
Vol / Avg.712.593K / 3.997K | Mkt Cap30.964M |
Day Range10.320 - 16.200 | 52 Wk Range8.465 - 42.000 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.070 | -0.070 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VTVT | vTv Therapeutics | 61.53% | 31M |
GLTO | Galecto | -0.02% | 16.3M |
CLRB | Cellectar Biosciences | -1.79% | 21.8M |
LUMO | Lumos Pharma | -8.31% | 21.8M |
EVAX | Evaxion Biotech | -2.51% | 21.6M |
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: Galecto (NASDAQ:GLTO), Cellectar Biosciences (NASDAQ:CLRB), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX) and Sensei Biotherapeutics (NASDAQ:SNSE).
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to fall to within 12 months (a possible -60.53% downside). 1 analyst firms have reported ratings in the last year.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $15.2 last updated Today at November 30, 2023 at 12:21 AM UTC.
There is no dividend information for vTv Therapeutics.
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.